Testagen

guinea pig

Also seen as: KEDG, Lys-Glu-Asp-Gly, prostate peptide bioregulator

The Dose Guy’s verdict
Sep 1, 2026
2 sources

A plausible pitch with nothing behind it. Testagen is a short bioregulator peptide sold for testicular and hormonal support, and no one has ever given it to a person in a study. Cell work and bird experiments, that is the whole file. If you want to support your hormonal axis, start with things that have been tested in humans. If the bioregulator concept is what interests you, thymalin and epitalon both have human data behind them.

Would I take it?Not yet. Zero human data.

What it is

Testagen is a four-amino-acid synthetic peptide, Lys-Glu-Asp-Gly, from the Khavinson bioregulator program. The idea is tissue-specific gene regulation: the peptide enters cells, interacts with DNA, and nudges the tissue it matches toward healthier function. The name says testicular support, but the published work is actually about thymus recovery and thyroid hormones in surgically altered birds. Even the preclinical data does not match the marketed claim.

It belongs to a large family of short peptides, each aimed at a different organ. Thymalin and epitalon have the most data behind them. Testagen sits at the back of the line, with less evidence than most of its siblings.

What the research shows

No human trials. Zero. Everything below is animal or in-vitro work. Read it as “interesting,” not “evidence it works in you.”

No human trial, no human safety study, no human pharmacokinetic study. The evidence base is cell assays and hypophysectomized chickens:

Fluorescein-labeled testagen produced marked fluorescence in the cytoplasm, nucleus, and nucleolus of incubated HeLa cells, confirming it enters cells and localizes to the nucleus.Biochemistry 2011 · in vitro
In hypophysectomized birds, testagen promoted recovery of thymic morphology regardless of age and outperformed epitalon, its sibling peptide Ala-Glu-Asp-Gly.Bull Exp Biol Med 2013 · animal
No human clinical trial of testagen or KEDG for any endpoint exists in the published literature.as of Aug 2026

Realistic protocols

I am not writing a dosing protocol for a peptide that has never been tested in a person. The community runs bioregulator peptides in short courses, typically low microgram-range doses for 10 to 20 days of subcutaneous injections, then a break, and testagen follows that pattern. If you run it anyway, go low, go short, log everything, and understand you are the trial.

Side effects

No human safety data exists, so everything here is inference from the bioregulator class:

anecdotalInjection-site irritation, the generic short-peptide complaint.
monitorA peptide designed to interact with gene expression, running without human dose-finding or toxicology. At minimum, pull blood work before and after a course.
unknownZero human safety data. A peptide that interacts with DNA and gene expression, with no toxicology or tolerability study in people, earns real caution.

Where to buy

No live listings from tracked vendors right now.